These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1528027)

  • 21. Protective anti-lipopolysaccharide monoclonal antibodies inhibit tumor necrosis factor production.
    Cody CS; Burd RS; Mayoral JL; Dunn DL
    J Surg Res; 1992 Apr; 52(4):314-9. PubMed ID: 1593869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
    Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis.
    Weiner DL; Kuppermann N; Saladino RA; Thompson CM; Novitsky TJ; Siber GR; Fleisher GR
    Crit Care Med; 1996 Sep; 24(9):1514-7. PubMed ID: 8797624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia.
    Roth RI; Su D; Child AH; Wainwright NR; Levin J
    J Infect Dis; 1998 Feb; 177(2):388-94. PubMed ID: 9466526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.
    Hockertz S
    Arzneimittelforschung; 1997 Jun; 47(6):793-6. PubMed ID: 9239462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of E5, an antiendotoxin monoclonal antibody, in the ovine pulmonary circulation.
    Chen TY; Zapol WM; Greene E; Robinson DR; Rubin RH
    J Appl Physiol (1985); 1993 Jul; 75(1):233-9. PubMed ID: 8376269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
    Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
    J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; D'Amato G; Del Prete MS; Orlando F; Kamysz W; Lukasiak J; Saba V; Scalise G
    Gut; 2003 Jun; 52(6):874-8. PubMed ID: 12740345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    J Med Vet Mycol; 1995; 33(2):131-6. PubMed ID: 7658305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; D'Amato G; Sisti V; Scalise G; Saba V
    Ann Surg; 2004 Feb; 239(2):251-6. PubMed ID: 14745334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.
    Bailat S; Heumann D; Le Roy D; Baumgartner JD; Rietschel ET; Glauser MP; Di Padova F
    Infect Immun; 1997 Feb; 65(2):811-4. PubMed ID: 9009348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide.
    Hoffman WD; Pollack M; Banks SM; Koev LA; Solomon MA; Danner RL; Koles N; Guelde G; Yatsiv I; Mouginis T
    J Infect Dis; 1994 Mar; 169(3):553-61. PubMed ID: 7512609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
    Opal SM; Palardy JE; Parejo N; Jasman RL
    Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
    Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of O-antigenic polysaccharide of Escherichia coli on endotoxin neutralizing activity of lysozyme.
    Liang AH; Sugawara N; Ohno N; Adachi Y; Yadomae T
    FEMS Immunol Med Microbiol; 1998 May; 21(1):79-87. PubMed ID: 9657324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms.
    Burd RS; Battafarano RJ; Cody CS; Farber MS; Ratz CA; Dunn DL
    Ann Surg; 1993 Sep; 218(3):250-9; discussion 259-61. PubMed ID: 8373268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.
    Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
    J Med Vet Mycol; 1995; 33(1):49-52. PubMed ID: 7650578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lipopolysaccharide on virulence of intestinal candida albicans.
    Henry-Stanley MJ; Hess DJ; Erickson EA; Garni RM; Wells CL
    J Surg Res; 2003 Jul; 113(1):42-9. PubMed ID: 12943809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.